South Korea Progressive Multifocal Leukoencephalopathy Treatment Market Size & Outlook, 2026-2034

South Korea Progressive Multifocal Leukoencephalopathy Treatment Market Insights

As per Reed Intelligence insights, the South Korea Progressive Multifocal Leukoencephalopathy Treatment Market stood at USD 4.32 Billion in 2025 and is anticipated to grow to USD 7.92 Billion by 2034.
The South Korea market is expected to advance at a CAGR of 7.02% from 2026 through 2034.
In 2025, Antiviral Therapy accounted for the highest share of the Treatment Type market size.
During the forecast period, Supportive Care is set to register the highest growth, making it the most lucrative Treatment Type segment.

Other Key Findings

In 2025, South Korea represented 1.05% of the overall global Progressive Multifocal Leukoencephalopathy Treatment Market size.
United States is projected to lead the global Progressive Multifocal Leukoencephalopathy Treatment Market size by 2034.
Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2034.
Singapore is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 4.12 Billion by 2034.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 4.32 Billion
Market Size In 2034	USD 7.92 Billion
Largest segment	Antiviral Therapy
Units	Revenue in USD Billion
CAGR	7.02% (2026-2034)
Segmnetation Covered
Treatment Type	Antiviral Therapy Immunotherapy Supportive Care
Application	HIV-associated PML Transplant-associated PML Cancer Therapy-associated PML
End-Use	Hospitals Specialty Clinics Research Institutes
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

South Korea Progressive Multifocal Leukoencephalopathy Treatment Market Treatment Type 2026-2034 (USD Billion)

Treatment Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Antiviral Therapy	XX.x	XX.x	XX.x	2.32	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Immunotherapy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Supportive Care	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

South Korea Progressive Multifocal Leukoencephalopathy Treatment Market Application 2026-2034 (USD Billion)

Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
HIV-associated PML	XX.x	XX.x	XX.x	1.99	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Transplant-associated PML	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Cancer Therapy-associated PML	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

South Korea Progressive Multifocal Leukoencephalopathy Treatment Market End-Use 2026-2034 (USD Billion)

End-Use	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Hospitals	XX.x	XX.x	XX.x	2.14	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Specialty Clinics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research Institutes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.